Device Endo-Mechanical

Echelon; Endopath

Payments companies reported to CMS as associated with Echelon; Endopath. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.3Massociated payments (2023-2025)

3,181clinicians with associated payments

5companies reporting

By year

2023 $375K

2024 $424K

2025 $497K

Payments reported as associated with Echelon; Endopath, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Surgery $791K

Colon & Rectal Surgery $161K

Thoracic Surgery (Cardiothoracic Vascular Surgery) $144K

Plastic Surgery $46K

Surgical Oncology $28K

Physician Assistant $25K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Echelon; Endopath

These are the largest totals companies reported as associated with Echelon; Endopath. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

Clinician	Location	Specialty	Associated payments (2023-2025)
Elizabeth Dovec	Lakeland, FL	Surgery	$198,956.25
Christopher Ducoin	Tampa, FL	Surgery	$88,689.61
Rahm Nazerali	Palo Alto, CA	Plastic Surgery	$44,631.73
Gina Adrales	Lutherville, MD	Surgery	$36,305.98
Isaac Felemovicius	Maple Grove, MN	Colon & Rectal Surgery	$34,179.42
Michael Snyder	Denver, CO	Surgery	$30,072.28
Sherief Shawki	Rochester, MN	Colon & Rectal Surgery	$28,090.10
Christopher Northup	Charlottesville, VA	Surgery	$27,047.94
Mehraneh Jafari	New York, NY	Colon & Rectal Surgery	$24,614.42
Leah Backhus	Palo Alto, CA	Thoracic Surgery (Cardiothoracic Vascular Surgery)	$23,602.11

Prescribed Echelon; Endopath?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

What this means, and what it doesn't

These payments are legal and common. Drug and device makers routinely pay for meals at educational events, consulting, speaking, travel, and research. Companies are required by federal law to report them; that's why this data exists.
A payment is not evidence of wrongdoing. Most clinicians who accept industry payments provide excellent care. Research payments in particular often reflect participation in clinical trials.
Context beats raw numbers. A few hundred dollars in sandwiches over several years is typical. What's worth understanding is scale, source, and purpose, which is what this page shows.
The data comes from companies, not doctors. Figures are "as reported to CMS" by the paying companies. Clinicians can dispute records through CMS's official process.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.